Task: Answer the multiple-choice question.
Query: Which drug exhibits a -32.153% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) CCC(=O)N(CCC(c1ccccc1)c1ccco1)Cc1cccs1
b.) CCN=C1SC(CC(=O)Nc2sc3c(c2C#N)CCCC3)C(=O)N1CC
c.) Cc1nn2c(NCCCN(C)C)c3c(nc2c1-c1ccccc1)CCCC3
Answer: c. Cc1nn2c(NCCCN(C)C)c3c(nc2c1-c1ccccc1)CCCC3
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nn2c(NCCCN(C)C)c3c(nc2c1-c1ccccc1)CCCC3
Cc1nn2c(NCCCN(C)C)c3c(nc2c1-c1ccccc1)CCCC3
N',N'-dimethyl-N-(2-methyl-3-phenyl-5,6,7,8-tetrahydropyrazolo[5,1-b]quinazolin-9-yl)propane-1,3-diamine